Your browser doesn't support javascript.
loading
Exosomal Delivery of AntagomiRs Targeting Viral and Cellular MicroRNAs Synergistically Inhibits Cancer Angiogenesis.
Wang, Jianguo; Jiang, Qiang; Faleti, Oluwasijibomi Damola; Tsang, Chi-Man; Zhao, Min; Wu, Gongfa; Tsao, Sai-Wah; Fu, Minyi; Chen, Yuxiang; Ding, Tengteng; Chong, Tuotuo; Long, Yufei; Yang, Xu; Zhang, Yuanbin; Cai, Yunxi; Li, Hanzhao; Peng, Manli; Lyu, Xiaoming; Li, Xin.
Afiliação
  • Wang J; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, China; Department of Radiation Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and
  • Jiang Q; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, China.
  • Faleti OD; Departmrent of Laboratory Medicine, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
  • Tsang CM; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China; Department of Anatomical and Cellular Pathology, State Key Laboratory of Translational Oncology, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong SAR, China.
  • Zhao M; PANACRO (Hefei) Pharmaceutical Technology Co., Ltd., Hefei, China.
  • Wu G; Department of Pathology, Zengcheng District People's Hospital of Guangzhou City, Guangzhou, China.
  • Tsao SW; School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong SAR, China.
  • Fu M; Otolaryngology-Head and Neck Surgery Department, Zhongshan City People's Hospital, Zhongshan, China.
  • Chen Y; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, China.
  • Ding T; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, China.
  • Chong T; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, China.
  • Long Y; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, China.
  • Yang X; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, China.
  • Zhang Y; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, China.
  • Cai Y; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, China.
  • Li H; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, China.
  • Peng M; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, China.
  • Lyu X; Departmrent of Laboratory Medicine, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China. Electronic address: xiaomlyu@smu.edu.cn.
  • Li X; Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, China. Electronic address: xinli268@gmail.com.
Mol Ther Nucleic Acids ; 22: 153-165, 2020 Aug 19.
Article em En | MEDLINE | ID: mdl-32927364

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Ther Nucleic Acids Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Ther Nucleic Acids Ano de publicação: 2020 Tipo de documento: Article